| Mild Cognitive Impairment: International Perspectives Contributor(s): Tuokko, Holly A. (Editor), Hultsch, David F. (Editor) |
|
 |
ISBN: 1841694665 ISBN-13: 9781841694665 Publisher: Psychology Press OUR PRICE: $109.25 Product Type: Hardcover - Other Formats Published: September 2006 Annotation: Mild Cognitive Impairment (MCI) has been identified as an important clinical transition between normal aging and the early stages of Alzheimer's disease (AD). Since treatments for AD are most likely to be most effective early in the course of the disease, MCI has become a topic of great importance and has been investigated in different populations of interest in many countries. This book brings together these differing perspectives on MCI for the first time. The introductory chapter is an overview of the evolving conceptions of cognitive change in later life and identifies the implicit and explicit assumptions underlying MCI research. The next two sections describe the findings emerging from studies conducted with different populations of interest (i.e., general population samples and specific samples) from different countries. Each chapter describes the types of information collected in the study, how MCI was defined, information pertaining to prevalence and incidence of MCI and important findings emerging from that study (e.g., Mayo Clinic, Kungsholmen Project, Melbourne Aging Study). The next section of the book describes the current status of intervention research for persons with MCI (e.g., pharmacologic, behavioral). A final chapter summarizes emerging trends in research on MCI and identifies promising areas for future research. This volume provides a comprehensive resource for clinicians, researchers, and students involved in the study, diagnosis, treatment, and rehabilitation of people with MCI |
| Additional Information |
| BISAC Categories: - Medical | Neurology - Psychology | Neuropsychology |
| Dewey: 616.804 |
| LCCN: 2006016450 |
| Series: Studies on Neuropsychology, Neurology, and Cognition |
| Physical Information: 1.01" H x 6.34" W x 9.58" (1.49 lbs) 336 pages |
| Descriptions, Reviews, Etc. |
| Publisher Description: Mild Cognitive Impairment (MCI) has been identified as an important clinical transition between normal aging and the early stages of Alzheimer's disease (AD). Since treatments for AD are most likely to be most effective early in the course of the disease, MCI has become a topic of great importance and has been investigated in different populations of interest in many countries. This book brings together these differing perspectives on MCI for the first time. This volume provides a comprehensive resource for clinicians, researchers, and students involved in the study, diagnosis, treatment, and rehabilitation of people with MCI. Clinical investigators initially defined mild cognitive impairment (MCI) as a transitional condition between normal aging and the early stages of Alzheimer's disease (AD). Because the prevalence of AD increases with age and very large numbers of older adults are affected worldwide, these clinicians saw a pressing need to identify AD as early as possible. It is at this very early stage in the disease course that treatments to slow the progress and control symptoms are likely to be most effective.Since the first introduction of MCI, research interest has grown exponentially, and the utility of the concept has been investigated from a variety of perspectives in different populations of interest (e.g., clinical samples, volunteers, population-based screening) in many different countries. Much variability in findings has resulted. Although it has been acknowledged that the differences observed between samples may be 'legitimate variations', there has been no attempt to understand what it is we have learned about MCI (i.e., common features and differences) from each of these perspectives. This book brings together information about MCI in different populations from around the world. Mild Cognitive Impairment will be an important resource for any clinician, researcher, or student involved in the study, detection, treatment, and rehabilitation of people with MCI. |